StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.85+0.41 (+1.49%)

Close on Nov 17, 2026Market cap $4.83BP/E –Yield –

Cogent Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cogent Biosciences's price to book ratio was 9.5× on Nov 11, 2026, against 18.6× a year earlier. Over the last 5 years it ranged from 1.1× to 18.6×, with a median of 3.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.5×−6.9
2025Dec 31, 202516.4×+13.7
2024Dec 31, 20242.7×+1.1
2023Dec 29, 20231.7×−1.1
2022Dec 30, 20222.8×+1.1
2021Dec 31, 20211.7×−3.3
2020Oct 30, 20205.0×+4.2
2019Dec 31, 20190.8×−1.2
2018Dec 31, 20181.9×–

More Cogent Biosciences figures

See a number that looks wrong?